Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Predictmedix AI Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1060)
•••
Post by Hiddensecretson Jul 18, 2020 12:40pm
285 Views
Post# 31284995

In 3 months scanners for fever sold: $ 100 million

In 3 months scanners for fever sold: $ 100 millionThe industry urgently wants to use any type of screening device for covid19.   

FLIR systems sold $ 100 million in 3 months this year and said that their scanners are being misused for medical purposes.   They were not designed to scan for fever. 

This OPENS the doors wide open to PMED whose scanning device is built for medical purposes.

=======================================



Oregon-based FLIR Systems.   FLIR sold more than $100 million worth of scanners that can screen for elevated skin temperatures in the first three months of this year

But Cannon (CEO of FLIR) said he fears the new wave of interest could lead to companies misusing the scanners or looking for medical insights they weren’t built to provide.

https://www.washingtonpost.com/technology/2020/05/11/thermal-scanners-are-latest-technology-being-deployed-detect-coronavirus-they-dont-really-work/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities